These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1302216)

  • 61. MoAb A33 shows promise in targeting colon cancer for radioimmunotherapy.
    Oncology (Williston Park); 1996 Apr; 10(4):553. PubMed ID: 8723287
    [No Abstract]   [Full Text] [Related]  

  • 62. Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund.
    Lancet; 1984 Jun; 1(8392):1441-3. PubMed ID: 6145882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PET imaging for planning cancer therapy.
    Eary JF
    J Nucl Med; 2001 May; 42(5):770-1. PubMed ID: 11337574
    [No Abstract]   [Full Text] [Related]  

  • 64. Radiotherapy for cancer of the colon.
    Backhouse BM; Howard N
    Clin Oncol; 1975 Sep; 1(3):245-51. PubMed ID: 55330
    [No Abstract]   [Full Text] [Related]  

  • 65. Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.
    Brökelmann J; Bockisch A; Vogel J; Reinsberg J; Oehr P; Biersack HJ; Krebs D
    Arch Gynecol Obstet; 1989; 244(4):193-206. PubMed ID: 2782949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lacto-N-fucopentaose III activity in the serum of patients with ovarian carcinoma.
    Cox CJ; Freedman RG; Fritsche HA
    Gynecol Obstet Invest; 1986; 21(3):164-8. PubMed ID: 3710289
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancer.
    Finkler NJ; Muto MG; Kassis AI; Weadock K; Tumeh SS; Zurawski VR; Knapp RC
    Gynecol Oncol; 1989 Sep; 34(3):339-44. PubMed ID: 2767526
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of patients with ovarian cancer using monoclonal antibodies.
    Lastoria S; Panza N; Esposito G; Vergara E; Castelli L; Caracò C; Battista C; Pacilio G; Salvatore M
    Biomed Pharmacother; 1992; 46(10):453-63. PubMed ID: 1306360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method.
    Garkavij M; Tennvall J; Strand SE; Nilsson R; Lindgren L; Chen J; Isaksson M; Eriksson H; Sjögren H
    Acta Oncol; 1996; 35(3):309-12. PubMed ID: 8679261
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiolabeled monoclonal antibodies for the diagnosis and treatment of ovarian carcinoma.
    Wahl RL
    Front Radiat Ther Oncol; 1990; 24():228-39. PubMed ID: 2187760
    [No Abstract]   [Full Text] [Related]  

  • 71. Radiation response of cultured human carcinoembryonic antigen-producing colon adenocarcinoma cells.
    Drewinko B; Yang LY; Romsdahl MM
    Int J Radiat Oncol Biol Phys; 1977; 2(11-12):1109-14. PubMed ID: 599062
    [No Abstract]   [Full Text] [Related]  

  • 72. Human antiidiotypic antibodies against OC125 strongly interfere with one-step assays of CA 125 employing OC125 and M11 antibodies.
    Reinsberg J; Gast B
    Clin Chem; 1994 Jun; 40(6):951-2. PubMed ID: 8087996
    [No Abstract]   [Full Text] [Related]  

  • 73. Characterization of the CA125 antigen secreted from a newly established human ovarian cancer cell line (SHIN-3).
    Imai S; Maeda H; Kiyozuka Y; Noda T; Moriyama I; Ichijo M
    Acta Pathol Jpn; 1989 Jan; 39(1):43-9. PubMed ID: 2469292
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy.
    Ward B; Mather S; Shepherd J; Crowther M; Hawkins L; Britton K; Slevin ML
    Br J Cancer; 1988 Nov; 58(5):658-62. PubMed ID: 3219277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Report of BACR workshop on monoclonal antibodies in breast and ovarian cancer, Brasenose College, Oxford March 17-19th 1991.
    Leonard RC; Fisken J; Roulston JE
    Br J Cancer; 1991 Oct; 64(4):796-7. PubMed ID: 1911231
    [No Abstract]   [Full Text] [Related]  

  • 76. Monoclonal antibodies in the treatment of ovarian cancer.
    Markowska J
    Eur J Gynaecol Oncol; 2003; 24(1):7-11. PubMed ID: 12691308
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Can radioimmunotherapy promote from an orphan drug to daily clinical practice?
    Mottaghy FM
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):865-6. PubMed ID: 24599376
    [No Abstract]   [Full Text] [Related]  

  • 78. Immuno-PET of cancer: a revival of antibody imaging.
    Boerman OC; Oyen WJ
    J Nucl Med; 2011 Aug; 52(8):1171-2. PubMed ID: 21764784
    [No Abstract]   [Full Text] [Related]  

  • 79. [Radioimmunotherapy of malignant diseases. Value and prospects].
    Mahé MA; Chatal JF
    Presse Med; 1995 Jan; 24(1):35-8. PubMed ID: 7899334
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Auger electron damage induced by radioiodinated iodine-125 monoclonal antibodies.
    Woo DV; Li DR; Brady LW; Emrich J; Mattis J; Steplewski Z
    Front Radiat Ther Oncol; 1990; 24():47-63; discussion 64-8. PubMed ID: 1692801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.